Report cover image

Global DNA and Gene Cloning Services Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 02, 2026
Length 192 Pages
SKU # APRC20798103

Description

The global DNA and Gene Cloning Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for DNA and Gene Cloning Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of DNA and Gene Cloning Services include Aragen Life Sciences, Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome and Sino Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for DNA and Gene Cloning Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of DNA and Gene Cloning Services, also provides the revenue of main regions and countries. Of the upcoming market potential for DNA and Gene Cloning Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the DNA and Gene Cloning Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global DNA and Gene Cloning Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for DNA and Gene Cloning Services revenue, projected growth trends, production technology, application and end-user industry.

DNA and Gene Cloning Services Segment by Company

Aragen Life Sciences
Bio-Techne
Charles River Laboratories
Curia
Eurofins
GenScript
Integrated DNA Technologies
MedGenome
Sino Biological
Syngene
Twist Bioscience

DNA and Gene Cloning Services Segment by Type

Gene Synthesis
Custom Cloning
Sub-cloning
Others

DNA and Gene Cloning Services Segment by Application

Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others

DNA and Gene Cloning Services Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA and Gene Cloning Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA and Gene Cloning Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA and Gene Cloning Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of DNA and Gene Cloning Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of DNA and Gene Cloning Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA and Gene Cloning Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

192 Pages
1 Market Overview
1.1 Product Definition
1.2 DNA and Gene Cloning Services Market by Type
1.2.1 Global DNA and Gene Cloning Services Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Gene Synthesis
1.2.3 Custom Cloning
1.2.4 Sub-cloning
1.2.5 Others
1.3 DNA and Gene Cloning Services Market by Application
1.3.1 Global DNA and Gene Cloning Services Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 DNA and Gene Cloning Services Market Dynamics
2.1 DNA and Gene Cloning Services Industry Trends
2.2 DNA and Gene Cloning Services Industry Drivers
2.3 DNA and Gene Cloning Services Industry Opportunities and Challenges
2.4 DNA and Gene Cloning Services Industry Restraints
3 Global Growth Perspective
3.1 Global DNA and Gene Cloning Services Market Perspective (2021-2032)
3.2 Global DNA and Gene Cloning Services Growth Trends by Region
3.2.1 Global DNA and Gene Cloning Services Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global DNA and Gene Cloning Services Market Size by Region (2021-2026)
3.2.3 Global DNA and Gene Cloning Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global DNA and Gene Cloning Services Revenue by Players
4.1.1 Global DNA and Gene Cloning Services Revenue by Players (2021-2026)
4.1.2 Global DNA and Gene Cloning Services Revenue Market Share by Players (2021-2026)
4.1.3 Global DNA and Gene Cloning Services Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global DNA and Gene Cloning Services Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global DNA and Gene Cloning Services Key Players Headquarters & Area Served
4.4 Global DNA and Gene Cloning Services Players, Product Type & Application
4.5 Global DNA and Gene Cloning Services Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global DNA and Gene Cloning Services Market CR5 and HHI
4.6.3 2025 DNA and Gene Cloning Services Tier 1, Tier 2, and Tier 3
5 DNA and Gene Cloning Services Market Size by Type
5.1 Global DNA and Gene Cloning Services Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global DNA and Gene Cloning Services Revenue by Type (2021-2032)
5.3 Global DNA and Gene Cloning Services Revenue Market Share by Type (2021-2032)
6 DNA and Gene Cloning Services Market Size by Application
6.1 Global DNA and Gene Cloning Services Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global DNA and Gene Cloning Services Revenue by Application (2021-2032)
6.3 Global DNA and Gene Cloning Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Aragen Life Sciences
7.1.1 Aragen Life Sciences Company Information
7.1.2 Aragen Life Sciences Business Overview
7.1.3 Aragen Life Sciences DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.1.4 Aragen Life Sciences DNA and Gene Cloning Services Product Portfolio
7.1.5 Aragen Life Sciences Recent Developments
7.2 Bio-Techne
7.2.1 Bio-Techne Company Information
7.2.2 Bio-Techne Business Overview
7.2.3 Bio-Techne DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.2.4 Bio-Techne DNA and Gene Cloning Services Product Portfolio
7.2.5 Bio-Techne Recent Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Company Information
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.3.4 Charles River Laboratories DNA and Gene Cloning Services Product Portfolio
7.3.5 Charles River Laboratories Recent Developments
7.4 Curia
7.4.1 Curia Company Information
7.4.2 Curia Business Overview
7.4.3 Curia DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.4.4 Curia DNA and Gene Cloning Services Product Portfolio
7.4.5 Curia Recent Developments
7.5 Eurofins
7.5.1 Eurofins Company Information
7.5.2 Eurofins Business Overview
7.5.3 Eurofins DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.5.4 Eurofins DNA and Gene Cloning Services Product Portfolio
7.5.5 Eurofins Recent Developments
7.6 GenScript
7.6.1 GenScript Company Information
7.6.2 GenScript Business Overview
7.6.3 GenScript DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.6.4 GenScript DNA and Gene Cloning Services Product Portfolio
7.6.5 GenScript Recent Developments
7.7 Integrated DNA Technologies
7.7.1 Integrated DNA Technologies Company Information
7.7.2 Integrated DNA Technologies Business Overview
7.7.3 Integrated DNA Technologies DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.7.4 Integrated DNA Technologies DNA and Gene Cloning Services Product Portfolio
7.7.5 Integrated DNA Technologies Recent Developments
7.8 MedGenome
7.8.1 MedGenome Company Information
7.8.2 MedGenome Business Overview
7.8.3 MedGenome DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.8.4 MedGenome DNA and Gene Cloning Services Product Portfolio
7.8.5 MedGenome Recent Developments
7.9 Sino Biological
7.9.1 Sino Biological Company Information
7.9.2 Sino Biological Business Overview
7.9.3 Sino Biological DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.9.4 Sino Biological DNA and Gene Cloning Services Product Portfolio
7.9.5 Sino Biological Recent Developments
7.10 Syngene
7.10.1 Syngene Company Information
7.10.2 Syngene Business Overview
7.10.3 Syngene DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.10.4 Syngene DNA and Gene Cloning Services Product Portfolio
7.10.5 Syngene Recent Developments
7.11 Twist Bioscience
7.11.1 Twist Bioscience Company Information
7.11.2 Twist Bioscience Business Overview
7.11.3 Twist Bioscience DNA and Gene Cloning Services Revenue and Gross Margin (2021-2026)
7.11.4 Twist Bioscience DNA and Gene Cloning Services Product Portfolio
7.11.5 Twist Bioscience Recent Developments
8 North America
8.1 North America DNA and Gene Cloning Services Revenue (2021-2032)
8.2 North America DNA and Gene Cloning Services Revenue by Type (2021-2032)
8.2.1 North America DNA and Gene Cloning Services Revenue by Type (2021-2026)
8.2.2 North America DNA and Gene Cloning Services Revenue by Type (2027-2032)
8.3 North America DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
8.4 North America DNA and Gene Cloning Services Revenue by Application (2021-2032)
8.4.1 North America DNA and Gene Cloning Services Revenue by Application (2021-2026)
8.4.2 North America DNA and Gene Cloning Services Revenue by Application (2027-2032)
8.5 North America DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
8.6 North America DNA and Gene Cloning Services Revenue by Country
8.6.1 North America DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America DNA and Gene Cloning Services Revenue by Country (2021-2026)
8.6.3 North America DNA and Gene Cloning Services Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe DNA and Gene Cloning Services Revenue (2021-2032)
9.2 Europe DNA and Gene Cloning Services Revenue by Type (2021-2032)
9.2.1 Europe DNA and Gene Cloning Services Revenue by Type (2021-2026)
9.2.2 Europe DNA and Gene Cloning Services Revenue by Type (2027-2032)
9.3 Europe DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
9.4 Europe DNA and Gene Cloning Services Revenue by Application (2021-2032)
9.4.1 Europe DNA and Gene Cloning Services Revenue by Application (2021-2026)
9.4.2 Europe DNA and Gene Cloning Services Revenue by Application (2027-2032)
9.5 Europe DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
9.6 Europe DNA and Gene Cloning Services Revenue by Country
9.6.1 Europe DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe DNA and Gene Cloning Services Revenue by Country (2021-2026)
9.6.3 Europe DNA and Gene Cloning Services Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China DNA and Gene Cloning Services Revenue (2021-2032)
10.2 China DNA and Gene Cloning Services Revenue by Type (2021-2032)
10.2.1 China DNA and Gene Cloning Services Revenue by Type (2021-2026)
10.2.2 China DNA and Gene Cloning Services Revenue by Type (2027-2032)
10.3 China DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
10.4 China DNA and Gene Cloning Services Revenue by Application (2021-2032)
10.4.1 China DNA and Gene Cloning Services Revenue by Application (2021-2026)
10.4.2 China DNA and Gene Cloning Services Revenue by Application (2027-2032)
10.5 China DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia DNA and Gene Cloning Services Revenue (2021-2032)
11.2 Asia DNA and Gene Cloning Services Revenue by Type (2021-2032)
11.2.1 Asia DNA and Gene Cloning Services Revenue by Type (2021-2026)
11.2.2 Asia DNA and Gene Cloning Services Revenue by Type (2027-2032)
11.3 Asia DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
11.4 Asia DNA and Gene Cloning Services Revenue by Application (2021-2032)
11.4.1 Asia DNA and Gene Cloning Services Revenue by Application (2021-2026)
11.4.2 Asia DNA and Gene Cloning Services Revenue by Application (2027-2032)
11.5 Asia DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
11.6 Asia DNA and Gene Cloning Services Revenue by Country
11.6.1 Asia DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia DNA and Gene Cloning Services Revenue by Country (2021-2026)
11.6.3 Asia DNA and Gene Cloning Services Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA DNA and Gene Cloning Services Revenue (2021-2032)
12.2 SAMEA DNA and Gene Cloning Services Revenue by Type (2021-2032)
12.2.1 SAMEA DNA and Gene Cloning Services Revenue by Type (2021-2026)
12.2.2 SAMEA DNA and Gene Cloning Services Revenue by Type (2027-2032)
12.3 SAMEA DNA and Gene Cloning Services Revenue Share by Type (2021-2032)
12.4 SAMEA DNA and Gene Cloning Services Revenue by Application (2021-2032)
12.4.1 SAMEA DNA and Gene Cloning Services Revenue by Application (2021-2026)
12.4.2 SAMEA DNA and Gene Cloning Services Revenue by Application (2027-2032)
12.5 SAMEA DNA and Gene Cloning Services Revenue Share by Application (2021-2032)
12.6 SAMEA DNA and Gene Cloning Services Revenue by Country
12.6.1 SAMEA DNA and Gene Cloning Services Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA DNA and Gene Cloning Services Revenue by Country (2021-2026)
12.6.3 SAMEA DNA and Gene Cloning Services Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.